Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial

To evaluate the safety, tolerability, and effect of fezolinetant on endometrial health over 52 weeks. METHODS: We conducted a phase 3, randomized, double-blind, 52-week safety study (SKYLIGHT 4 [Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal-Perry, Genevieve, Cano, Antonio, Lederman, Samuel, Nappi, Rossella E., Santoro, Nanette, Wolfman, Wendy, English, Marci, Franklin, Catherine, Valluri, Udaya, Ottery, Faith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026946/
https://www.ncbi.nlm.nih.gov/pubmed/36897180
http://dx.doi.org/10.1097/AOG.0000000000005114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026946/
https://www.ncbi.nlm.nih.gov/pubmed/36897180
http://dx.doi.org/10.1097/AOG.0000000000005114

Ejemplares similares